文献速递妇产影像泌尿生殖介入US

体外受精前输卵管积水的治疗:系统综述与网状Meta分析

Hydrosalpinx treatment before in-vitro fertilization: systematic review and network meta-analysis.
PubMed 文献 · Ultrasound Obstet Gynecol · 2025-01-26

该系统综述与网状Meta分析比较了输卵管切除术、腹腔镜近端输卵管阻塞术、输卵管内置入装置、超声引导下抽吸、硬化治疗和期待治疗对体外受精前输卵管积水的安全性和有效性。主要分析纳入9项随机对照试验,另有17项观察性研究纳入聚合分析。网状Meta分析未能支持任何输卵管积水治疗方法提高活产率,但输卵管切除术和超声引导下抽吸可提高持续妊娠率,输卵管切除术和腹腔镜近端输卵管阻塞术可提高临床妊娠率,强化了当前推荐。

要点

  • 输卵管积水各治疗方法的活产率无显著差异,腹腔镜近端输卵管阻塞术SUCRA值最高(0.9)。
  • 与不治疗相比,输卵管切除术和超声引导下抽吸显著提高持续妊娠率(OR分别为4.35和2.80)。
  • 与不治疗相比,输卵管切除术和腹腔镜近端输卵管阻塞术显著提高临床妊娠率(OR分别为2.24和2.55)。

核心结论

  • 该网状Meta分析未能支持任何输卵管积水治疗方法改善体外受精-胚胎移植后的活产率,但输卵管切除术和超声引导下抽吸对持续妊娠率的有益效应以及输卵管切除术和腹腔镜近端输卵管阻塞术对临床妊娠率的有益效应强化了当前推荐。

研究设计与样本

  • 系统综述与网状Meta分析,主要分析纳入9项随机对照试验,聚合分析另纳入17项观察性研究。

诊断标准与关键数值

  • 与不治疗相比,输卵管切除术的持续妊娠率OR为4.35(95%CI 1.70-11.14),超声引导下抽吸的持续妊娠率OR为2.80(95%CI 1.03-7.58)。
  • 与不治疗相比,输卵管切除术的临床妊娠率OR为2.24(95%CI 1.30-3.86),腹腔镜近端输卵管阻塞术的临床妊娠率OR为2.55(95%CI 1.20-5.51)。
  • 随机对照试验网状Meta分析中,输卵管积水各治疗方法的活产率无显著差异,腹腔镜近端输卵管阻塞术SUCRA值最高(0.9)。
  • 聚合网状Meta分析中,与不治疗相比,硬化治疗显著提高活产率;输卵管切除术、超声引导下抽吸和腹腔镜近端输卵管阻塞术的持续妊娠率高于未治疗患者。
  • 聚合网状Meta分析中,除输卵管内置入装置外,所有干预措施均较不治疗提高临床妊娠率;腹腔镜近端输卵管阻塞术对临床妊娠率的影响大于超声引导下抽吸。

临床应用与阅片要点

  • 作者认为,基于聚合分析,硬化治疗可能成为传统腹腔镜技术的有效替代方案,并具有有利的安全性特征。
  • 作者指出,输卵管切除术和超声引导下抽吸对持续妊娠率的有益效应以及输卵管切除术和腹腔镜近端输卵管阻塞术对临床妊娠率的有益效应强化了当前推荐。
  • 网状Meta分析将腹腔镜近端输卵管阻塞术排名为提高临床妊娠率和降低流产率最有效的治疗,而硬化治疗在卵巢对体外受精刺激的反应方面被认为更安全。

局限性

  • 临床妊娠率比较存在一定异质性。
  • 原文未报告其他局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

OBJECTIVE: To compare the safety and effectiveness of different methods, both ablative and non-ablative, to treat hydrosalpinx in infertile patients before in-vitro fertilization embryo transfer (IVF-ET) via a systematic review and network meta-analysis (NMA).

METHODS: A structured literature search was conducted in common citation databases. Eligibility criteria included peer-reviewed randomized controlled trials (RCTs) or cohort studies comparing the effectiveness and/or safety of different hydrosalpinx treatments, including salpingectomy, laparoscopic proximal tubal occlusion (LTO), insertion of an intratubal device (ITD), ultrasound-guided aspiration, sclerotherapy and expectant management. Primary outcomes were live birth, ongoing pregnancy and clinical pregnancy. Miscarriage, ectopic pregnancy and procedural complications were considered as secondary outcomes. The main NMA included only RCTs, while observational studies were included in a secondary aggregate NMA. Pooled effects were summarized as odds ratios (ORs) with 95% CI for direct and indirect comparisons, derived from random-effects models. Imprecision of NMA estimates was assessed by comparison of their 95% CIs with predefined thresholds for effect size considered to represent clinical relevance (OR < 0.9 or >1.1). Heterogeneity for NMA findings was estimated using the variance of the distribution of the underlying treatment effects (τ2), expressed as a 95% prediction interval. Surface under the cumulative ranking curve (SUCRA) was used to predict relative treatment rankings for each outcome.

RESULTS: The main analysis included nine RCTs, while an additional 17 observational studies were incorporated into the aggregate analysis. The NMA of RCTs revealed no significant differences in live birth rate between hydrosalpinx treatment methods, with LTO achieving the highest SUCRA value (0.9). Salpingectomy and ultrasound-guided aspiration significantly increased the ongoing pregnancy rate compared with no treatment (OR, 4.35 (95% CI, 1.70-11.14) and 2.80 (95% CI, 1.03-7.58), respectively), with salpingectomy having the highest SUCRA value (0.9). Clinical pregnancy rate was significantly higher following salpingectomy (OR, 2.24 (95% CI, 1.30-3.86)) and LTO (OR, 2.55 (95% CI, 1.20-5.51)) compared with no treatment, despite some heterogeneity; LTO had the highest SUCRA value (0.8). NMA showed no significant differences in secondary outcomes between treatments. Aggregate NMA indicated that sclerotherapy significantly increased the live birth rate compared with no treatment. Higher ongoing pregnancy rate was observed in patients treated with salpingectomy, ultrasound-guided aspiration and LTO compared to untreated patients, with salpingectomy having the highest SUCRA value (0.9). Except for ITD insertion, all interventions increased the clinical pregnancy rate compared with no treatment. LTO had a greater effect on clinical pregnancy rate compared to ultrasound-guided aspiration, with no significant differences in other pairwise comparisons. NMA ranked LTO as the most effective treatment for increasing the clinical pregnancy rate and reducing the miscarriage rate, while sclerotherapy was deemed safer with regard to the ovarian response to IVF stimulation.

CONCLUSIONS: This NMA fails to support the effectiveness of any hydrosalpinx treatment to improve the live birth rate following IVF-ET, although the beneficial effect of salpingectomy and ultrasound-guided aspiration on ongoing pregnancy rate and of salpingectomy and LTO on clinical pregnancy rate reinforces current recommendations. Based on the aggregated analysis, sclerotherapy could be an effective alternative to conventional laparoscopic techniques, with a favorable safety profile. © 2024 The Author(s). Ultrasound in Obstetrics & Gynecology published by John Wiley & Sons Ltd on behalf of International Society of Ultrasound in Obstetrics and Gynecology.

来源:Ultrasound Obstet Gynecol,查看原文。版权归原作者所有。

引用

  1. Pérez-Milán F, Caballero-Campo M, Carrera-Roig M, et al. Hydrosalpinx treatment before in-vitro fertilization: systematic review and network meta-analysis. Ultrasound Obstet Gynecol. 2025. PMID: 38764191. doi:10.1002/uog.27697

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。